Comparison of Outcomes of HLA-Matched Related, Unrelated, or HLA-Haploidentical Related Hematopoietic Cell Transplantation following Nonmyeloablative Conditioning for Relapsed or Refractory Hodgkin Lymphoma-Reference-Cited by-同舟云学术

Comparison of Outcomes of HLA-Matched Related, Unrelated, or HLA-Haploidentical Related Hematopoietic Cell Transplantation following Nonmyeloablative Conditioning for Relapsed or Refractory Hodgkin Lymphoma

Published:2008-11 Issue:11 Volume:14 Page:1279-1287
ISSN:1083-8791
Container-title:Biology of Blood and Marrow Transplantation
language:en
Short-container-title:Biology of Blood and Marrow Transplantation

Author:

Burroughs Lauri M.,O'Donnell Paul V.,Sandmaier Brenda M.,Storer Barry E.,Luznik Leo,Symons Heather J.,Jones Richard J.,Ambinder Richard F.,Maris Michael B.,Blume Karl G.,Niederwieser Dietger W.,Bruno Benedetto,Maziarz Richard T.,Pulsipher Michael A.,Petersen Finn B.,Storb Rainer,Fuchs Ephraim J.,Maloney David G.

Publisher

Elsevier BV

Subject

Transplantation,Hematology

Reference55 articles.

1. Autologous stem cell transplantation in Hodgkin's disease (review);Avivi;Ann Oncol,2002

2. High-dose therapy and autologous hematopoietic progenitor cell transplantation for recurrent or refractory Hodgkin's disease: analysis of the Stanford University results and prognostic indices;Horning;Blood,1997

3. Autotransplants for Hodgkin's disease in first relapse or second remission: a report from the Autologous Blood and Marrow Transplant Registry (ABMTR);Lazarus;Bone Marrow Transplant,2001

4. Autotransplants for Hodgkin's disease in patients never achieving remission: a report from the Autologous Blood and Marrow Transplant Registry;Lazarus;J Clin Oncol,1999

5. Allogeneic bone marrow transplantation in patients who relapse after autologous transplantation;Tsai;Bone Marrow Transplant,1997

Cited by 242 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. PTCy vs CNI–based GVHD prophylaxis in HLA-matched transplants for Hodgkin lymphoma: a study of the LWP of the EBMT;Blood Advances;2024-07-26

2. Current status of conditioning regimens in haploidentical hematopoietic cell transplantation;Hematology;2024-03-21

3. Remission of relapsed/refractory classical Hodgkin lymphoma induced by brentuximab vedotin and pembrolizumab combination after allogeneic hematopoietic stem cell transplantation: a case report;Frontiers in Immunology;2024-03-06

4. Post-Transplantation Cyclophosphamide-Based Graft-versus-Host Disease Prophylaxis in HLA-Matched and Haploidentical Donor Transplantation for Patients with Hodgkin Lymphoma: A Comparative Study of the Lymphoma Working Party of the European Society for Blood and Marrow Transplantation;Transplantation and Cellular Therapy;2024-02

5. Graft-versus-Host Disease Prophylaxis with Post- Transplantation Cyclophosphamide in Chronic Myeloid Leukemia Patients Undergoing Allogeneic Hematopoietic Cell Transplantation from an Unrelated or Mismatched Related Donor: A Comparative Study from the Chronic Malignancies Working Party of the EBMT (CMWP-EBMT);Transplantation and Cellular Therapy;2024-01